Marshall Wace’s Clover Health Investments CLOV Stock Holding History

Marshall Wace’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.19M	Buy	+1,563,189	New	+$5.31M	0.01%	1117
2025 Q3	–	Sell	-3,523,047	Closed	-$9.83M	–	2954
2025 Q2	$9.83M	Sell	3,523,047 -1,052,480	-23%	-$3.46M	0.01%	845
2025 Q1	$16.4M	Buy	4,575,527 +805,762	+21%	+$3.24M	0.02%	573
2024 Q4	$11.9M	Buy	3,769,765 +2,360,902	+168%	+$8.44M	0.01%	733
2024 Q3	$3.97M	Buy	1,408,863 +1,364,007	+3,041%	+$3.12M	﹤0.01%	1089
2024 Q2	$55.2K	Buy	+44,856	New	+$40.3K	﹤0.01%	2441
2022 Q1	–	Sell	-1,245,630	Closed	-$4.63M	–	3417
2021 Q4	$4.63M	Buy	+1,245,630	New	+$7.64M	0.01%	1414

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace's CLOV Position: Q2 2026 in Review

Marshall Wace opened a new position in Clover Health Investments (CLOV) in Q2 2026: 1,563,189 shares worth $8.19M. The stake represents 0.01% of the portfolio and ranks #1117 among its holdings. This is a return to the name: Marshall Wace previously reported a position in CLOV as recently as Q2 2025.

Marshall Wace first reported a position in CLOV in Q4 2021 and has held it in 7 quarters since. The position peaked at $16.4M in Q1 2025. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Marshall Wace held 1,563,189 shares of Clover Health Investments worth $8.19M as of Q2 2026.
Clover Health Investments was a new Marshall Wace position in Q2 2026.
Clover Health Investments made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1117 holding.
Marshall Wace first reported a position in Clover Health Investments in Q4 2021 and has held it in 7 quarters since.
Marshall Wace's Clover Health Investments position peaked at $16.4M in Q1 2025.
226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.